This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Title: Josue Sznitman: Innovator in Targeted Delivery Systems
Introduction
Josue Sznitman is a prominent inventor based in Haifa, Israel. He has made significant contributions to the field of targeted delivery systems, particularly in the area of aerosols and magnetic particles. With a total of 4 patents, Sznitman is recognized for his innovative approaches to enhancing the efficacy of drug delivery methods.
Latest Patents
One of Sznitman's latest patents focuses on the targeted delivery of aerosols containing magnetized active agents. This invention provides compositions, kits, and methods for depositing a composition comprising a plurality of magnetic particles to a target site within a subject's respiratory tract. By delivering the composition via controlled inhalation and applying a magnetic field, the particles can be effectively captured at the desired target site. This method represents a significant advancement in the field of respiratory therapies.
Career Highlights
Sznitman is affiliated with the Technion Research & Development Foundation Ltd., where he continues to develop and refine his innovative ideas. His work has garnered attention for its potential to improve treatment outcomes for patients requiring targeted therapies.
Collaborations
Throughout his career, Sznitman has collaborated with notable colleagues, including Yan Ostrovski and Rami Fishler. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Josue Sznitman is a key figure in the realm of targeted delivery systems, with a focus on innovative aerosol technologies. His contributions are paving the way for more effective therapeutic interventions in respiratory medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
